Contents

Current Cancer Drug Targets, Volume 4 - Number 2

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

, 4(2): 111 - 124

Patrick Onyango


DOI: 10.2174/1568009043481588




Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy

, 4(2): 125 - 146

Johann Hofmann


DOI: 10.2174/1568009043481579




Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications

, 4(2): 147 - 163

Albert F. Kabore, James B. Johnston and Spencer B. Gibson


DOI: 10.2174/1568009043481551




Transforming Growth Factor-β Superfamily: Evaluation as Breast Cancer Biomarkers and Preventive Agents

, 4(2): 165 - 182

V. Gupta, D. P. Harkin, H. Kawakubo and S. Maheswaran


DOI: 10.2174/1568009043481542




A Rationale for Inhibiting Progesterone-Related Pathways to Combat Breast Cancer

, 4(2): 183 - 189

Michael R. Moore


DOI: 10.2174/1568009043481515




Novel Fluoropyrimidines: Improving the Efficacy and Tolerability of Cytotoxic Therapy

, 4(2): 191 - 204

Russell D. Petty and J. Cassidy


DOI: 10.2174/1568009043481533




Targeted Histone Deacetylase Inhibition for Cancer Therapy

, 4(2): 205 - 218

D. M. Vigushin and R. C. Coombes


DOI: 10.2174/1568009043481560




AT Islands - Their Nature and Potential for Anticancer Strategies

, 4(2): 219 - 234

Jan M. Woynarowski


DOI: 10.2174/1568009043481524




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science